High Tide, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Harkirat Grover
- Full Time Employees
- 1,832
- Sector
- Retail trade
- Industry
- Specialty stores
- Address
- 11127 - 15 Street NE Calgary AB Canada T3K 2M4
- IPO Date
- Jul 22, 2022
- Website
- hightideinc.com
- Similar Companies
- Business
- High Tide Inc. stands as a prominent, retail-focused entity within the global cannabis sector, headquartered in Calgary, Canada, and founded in 2009. The company operates primarily through its extensive network of Canna Cabana retail cannabis stores across Canada, notably being the largest non-franchised cannabis retailer by revenue in the nation. High Tide's business model is characterized by its innovative discount club program, the Cabana Club, which had surpassed 1.9 million members in Canada by April 2025, driving significant customer loyalty and repeat business. This loyalty program is also active on its international e-commerce platforms. Beyond its physical retail footprint, which by November 2025 has reached 215 Canna Cabana locations across Canada, including a strong presence in Alberta and Ontario, High Tide also maintains a robust e-commerce segment. This includes a suite of leading online platforms for smoking accessories and CBD products such as Grasscity.com, SmokeCartel.com, DailyHighClub.com, and Dankstop.com, catering to a broad international customer base across the United States and Europe. High Tide’s operations are vertically integrated and diversified, encompassing not only retail and e-commerce but also the design, manufacturing, and wholesale distribution of consumption accessories, including proprietary brands. The company further provides data analytics services, leveraging insights from its vast customer base to refine its offerings and enhance customer experience. In a significant strategic move, High Tide announced its entry into the fast-growing German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH in September 2025, marking a pivotal step in its global expansion strategy and diversifying its revenue streams beyond Canada. The company consistently reports strong financial results, with record revenue and positive free cash flow, and has been recognized as one of Canada's Top Growing Companies for five consecutive years. High Tide continues its growth trajectory, aiming to expand its Canadian store count to 350 locations and its Cabana Club membership to 3 million.
Company News
High Tide Resources Reports Up to 68.2% Fe Concentrate with Very Low Impurities from Labrador West Iron Project
High Tide Acquires Established Cannabis Store in Chestermere, Alberta
High Tide to Open First Canna Cabana in Peterborough, Ontario
High Tide pairs a growth ranking with faster EBITDA gains
High Tide Named to Report on Business Ranking of Canada's Top Growing Companies for Sixth Consecutive Year
Retailer Insights Report Shows Canna Cabana Widening Its Lead Among Canadian Cannabis Retailers
High Tide Inc. (HITI:CA) Q3 2026 Earnings Call Transcript
High Tide Q3 Earnings Call Highlights
High Tide Reports Record-Breaking Third Quarter 2026 Financial Results
High Tide: German Expansion Just Added Another Bullish Catalyst
High Tide Continues Canadian Expansion with Three New Canna Cabana Locations
High Tide to Announce Third Fiscal Quarter 2026 Financial Results
High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders
HIGH TIDE CLOSES $40 MILLION SENIOR SECURED CREDIT FACILITIES
High Tide Announces Preliminary Q3 2026 Guidance
High Tide Closes Acquisition of Northern Helm, Adding Four Retail Cannabis Stores in Ontario
High Tide to Open New Canna Cabana in Ottawa, Ontario
High Tide CEO Raj Grover Answered Shareholder Questions During Reddit AMA
High Tide Announces Adoption of New Shareholder Rights Plans
High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026